The Future of DCTs is Bright According to Big Pharma and FDA
The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...
Moe Alsumidaie
Unlocking Clinical Trials in Africa: New Insights
The continent of Africa stands at a fascinating juncture in clinical trials, presenting a blend of untapped potential and...
Tufts CSDD: New Insights on The Clinical Trial Industry
The landscape of clinical trials is undergoing a transformation marked by increasing intricacy and operational challenges. Ken Getz, Executive...
Walgreens New Decentralized Clinical Trials Model in Action
The 2024 SCOPE Summit, a pivotal event in clinical trials, showcased innovative strategies to transform patient recruitment and trial...
Unpacking FDA’s New Guidance on Facilitating Understanding in eConsent
Informed consent is not just a procedural formality but a basis of ethical practice, ensuring that participants fully understand...
Single Sign-On Technology: Easing Study Site Burden Now
In the intricate and rapidly evolving landscape of clinical trials, integrating efficient and cutting-edge technology solutions has become a...
Stanford’s New Leap in Personalized Medicine and Trials
The forefront of personalized medicine is dramatically reshaped by advancements in biomarker discovery and digital health technologies (DHTs) –...
Digital Health Technologies: New Era in Clinical Research
Digital health technologies (DHTs) are revolutionizing the landscape of clinical research, pushing us toward more innovative and patient-centered trial...
Remarkable Edge in Cancer Vaccine Treatment: New Hope
In this interview, we engage with Andrew Allen, a pioneering force in the field of immunotherapy and the co-founder...
Unique Thyroid Cancer Tests: New Hope Unveiled
In the rapidly evolving landscape of medical research, particularly in the realm of cancer treatment, the development and application...